Article
Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.
Cancer medicine - 1 Oct 2012
Ducros Elodie, Mirshahi Shah Soltan, Faussat Anne-Marie, Mirshahi Pezhman, Dimicoli Sophie, Tang Ruoping, Pardo Julia, Ibrahim Jdid, Marie Jean-Pierre, Therwath Amu, Soria Jeannette, Mirshahi Massoud
Abstract excerpt
Elevated plasma level of soluble endothelial protein C receptor (sEPCR) may be an indicator of thrombotic risk. The present study aims to correlate leukemia-associated hypercoagulability to high level plasma sEPCR and proposes its measurement in routine clinical practice. EPCR expressions in leukemic cell lines were determined by flow cytometry, immunocytochemistry, and reverse transcription polymerase chain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
